Copy Link Print Information

Tralokinumab

(Synonyms: CAT354)
2 Cited Publications
Customer Review

Based on 2 publication(s) in Google Scholar

Tralokinumab (CAT354) is a humanized IgG4 monoclonal antibody that specifically binds to and neutralizes IL-13. Tralokinumab can be used in the research of diseases such as asthma, atopic dermatitis, and pulmonary fibrosis.

For research use only. We do not sell to patients.

  • Purity: 99.12%
  • CAS No.: 1044515-88-9
  • Molecular Weight:144.14 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Tralokinumab
  • Experimental Validation Results for Tralokinumab
  • Experimental Validation Results for Tralokinumab
  • Experimental Validation Results for Tralokinumab
  • Tralokinumab Chemical Structure
    Tralokinumab Chemical Structure
CAS No.: 1044515-88-9
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Tralokinumab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Tralokinumab

More
Customer Validation & Images
Cell Imaging/StainingIF
  • Cell Imaging/Staining
  • IF

All Interleukin Related Isoforms

More

All Caspase Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG4 lambda

  • 1/16

    Tralokinumab (HY-P99053) neutralizes Recombinant Human IL-13 (HY-P70568) induced proliferation in the TF-1 human erythroleukemic cell line. The Neutralization Dose (ND50) for this effect is 0.6630 μg/mL in the presence of 10 ng/mL Recombinant Human IL-13.

  • 1/16

    Tralokinumab purchased from MedChemExpress. Usage Cited in: ACS Nano. 2025 Sep 16;19(36):32361-32373. [Abstract]

    Customer Validation
     Representative images of fibrosis-induced spheroids subjected to microfluidic deformation analysis, comparing untreated control, antifibrotic drug NTD, and anti-interleukin drugs TCZ, STX, DUP, and TRA. Mab (5 μg/mL, 1 d) were added, Scale bars indicate 100 μm.

  • 1/16

    Tralokinumab purchased from MedChemExpress. Usage Cited in: ACS Nano. 2025 Sep 16;19(36):32361-32373. [Abstract]

    Customer Validation
     Confocal fluorescence images showing the expression of collagen-1 and α-SMA in spheroids treated with NTD, TCZ, STX, DUP, and TRA. Mab (5 μg/mL, 1 d) were added, Scale bars indicate 100 μm.

  • Tralokinumab Chemical Structure
    1/16
  • Tralokinumab
  • Tralokinumab (HY-P99053) neutralizes Recombinant Human IL-13 (HY-P70568) induced proliferation in the TF-1 human erythroleukemic cell line. The Neutralization Dose (ND50) for this effect is 0.6630 μg/mL in the presence of 10 ng/mL Recombinant Human IL-13.